Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:LPC 22:4(7Z,10Z,13Z,16Z))

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST002576 AN005610 Role of environmental toxicants in obesity-related cardiovascular disease: Plasma untargeted LC-HRMS analysis (part 1 of 3) Blood Human Heart disease Boston University LC-MS
ST001783 AN002894 Performance of Three Differential Metabolites at Different TSS within 20 days Blood Mouse Hebei medical university LC-MS
ST001276 AN002117 Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001275 AN002116 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University LC-MS
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
  logo